Related references
Note: Only part of the references are listed.The 5-HT transporter transactivates the PDGFβ receptor in pulmonary artery smooth muscle cells
Yinglin Liu et al.
FASEB JOURNAL (2007)
Dysfunctional intracellular trafficking in the pathobiology of pulmonary arterial hypertension
Pravin B. Sehgal et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Inhibition of transforming growth factor β signaling reduces pancreatic adenocarcinoma growth and invasiveness
Nicholas J. Gaspar et al.
MOLECULAR PHARMACOLOGY (2007)
The transforming growth factor-beta/Smad2,3 signalling axis is impaired in experimental pulmonary hypertension
A. Zakrzewicz et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Effect of transforming growth factor-β receptor I kinase inhibitor 2,4-disubstituted pteridine (SD-208) in chronic allergic airway inflammation and remodeling
Sum Yee Leung et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension
Kaori Ihida-Stansbury et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
Aneurysm syndromes caused by mutations in the TGF-β receptor
Bart L. Loeys et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Transforming growth factor-β receptor type 1 (TGFβRI) kinase activity but not p38 activation is required for TGF βRI-induced myofibroblast differentiation and profibrotic gene expression
Ann M. Kapoun et al.
MOLECULAR PHARMACOLOGY (2006)
Apoptosis of pulmonary microvascular endothelial cells stimulates vascular smooth muscle cell growth
Seiichiro Sakao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)
Reversal of experimental pulmonary hypertension by PDGF inhibition
RT Schermuly et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Increased susceptibility to pulmonary hypertension in heterozygous BMPR2-mutant mice
YL Song et al.
CIRCULATION (2005)
Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension
SL Merklinger et al.
CIRCULATION (2005)
Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension
H Lepetit et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Progressive transforming growth factor β1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor
P Bonniaud et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Monocrotaline pyrrole-induced endothelial cell megalocytosis involves a Golgi blockade mechanism
M Shah et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2
BL Loeys et al.
NATURE GENETICS (2005)
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
E Takimoto et al.
NATURE MEDICINE (2005)
Regulation of the TGFβ signalling pathway by ubiquitin-mediated degradation
L Izzi et al.
ONCOGENE (2004)
Impaired transforming growth factor-β signaling in idiopathic pulmonary arterial hypertension
A Richter et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia
H Beppu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
Differential effects of TGF-β1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells
KKK Sheares et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia
RE Harrison et al.
JOURNAL OF MEDICAL GENETICS (2003)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFP/ALK5 signaling
MJ Goumans et al.
MOLECULAR CELL (2003)
Mechanisms of TGF-β signaling from cell membrane to the nucleus
YG Shi et al.
CELL (2003)
Mechanisms of TGF-β signaling in regulation of cell growth and differentiation
A Moustakas et al.
IMMUNOLOGY LETTERS (2002)
Immunohistochemical study of endothelin-1 and matrix metalloproteinases in plexogenic pulmonary arteriopathy
K Matsui et al.
PATHOLOGY RESEARCH AND PRACTICE (2002)
Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension
E Frisdal et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
Altered growth responses of muscle cells from patients pulmonary artery smooth with primary pulmonary hypertension to transforming growth factor-β1 and bone morphogenetic proteins
NW Morrell et al.
CIRCULATION (2001)
Activation of the TGF-β/activin-Smad2 pathway during allergic airway inflammation
A Rosendahl et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2001)
Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: Role of proteases
VA Fadok et al.
JOURNAL OF IMMUNOLOGY (2001)
BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension
RD Machado et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Complete reversal of fatal pulmonary hypertension in rats by a serine elastase inhibitor
KN Cowan et al.
NATURE MEDICINE (2000)
Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension
KB Lane et al.
NATURE GENETICS (2000)
Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease
KN Cowan et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Mechanical strain-induced extracellular matrix production by human vascular smooth muscle cells - Role of TGF-beta(1)
CJ O'Callaghan et al.
HYPERTENSION (2000)
Share Paper
